RxDoctor Payments Data

Heather Burchett

Psychiatric/Mental Health · Richmond, KYNPI 1528375672

Payments from drug & device makers

$4,324in general payments, 2019–2025

Across 127 payments — averaging $34.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Axsome Therapeutics, Inc.$615
  • Lundbeck LLC$416
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$294
  • Ironshore Pharmaceuticals Inc.$252
  • Corium, LLC$236
  • plus $920 from 12 others

What the payments were for

  • Food & beverage$4,324100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,324 in reported general payments places this provider in the 85th percentile of 946 psychiatric/mental health providers in Kentucky.

See all psychiatric/mental health providers in Kentucky

Medicare billing

Part B allowed, 2024
$8,994
Medicare patients
21
Services billed
100

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl38$55,345
NuedextaDextromethorphan Hbr/Quinidine11$16,957
AuvelityDextromethorphan Hbr/Bupropion14$15,260
TrintellixVortioxetine Hydrobromide12$6,560
Desvenlafaxine Succinate ErDesvenlafaxine Succinate52$4,225
Aripiprazole17$3,228
Zolpidem Tartrate ErZolpidem Tartrate17$1,835
Vilazodone Hcl33$1,521
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine57$1,420
Ziprasidone Hcl12$1,078
Duloxetine Hcl64$943
Divalproex Sodium ErDivalproex Sodium17$909
Bupropion XlBupropion Hcl73$852
Alprazolam139$678
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine13$627

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$1,590$55,34538 claims
Axsome Therapeutics, Inc.Auvelity$615$15,26014 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$55$6,56012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 946 psychiatric/mental health providers in Kentucky.

Other psychiatric/mental health in Richmond

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →